M2I Life Sciences
M2I Life Sciences is a French industrial group offering pheromone-based biocontrol crop protection products and CDMO custom synthesis services for pharmaceutical and fine chemistry clients, serving professional agriculture and pharma customers across 80 countries.
- Company typePrivate
- Founded2013
- HeadquartersLacq, France
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What M2I Life Sciences does
M2I Life Sciences is a French industrial group that operates two business divisions from four sites in France (Saint-Cloud headquarters, Lacq R&D and microencapsulation production, Parnac production and agronomic field trials, and the historic Salin-de-Giraud fine chemistry facility acquired in 2012). The Biocontrol division develops and sells pheromone-based crop protection products that use mating disruption technology to substitute for conventional chemical pesticides, available in eight formulation formats (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) and a growing catalog of targeted products for specific pest-crop combinations across 60+ crop types, distributed in 80 countries. The Chemistry & Life Sciences division operates as a CDMO offering custom synthesis, contract manufacturing, and proprietary pharmaceutical actives and intermediates, with specialist capabilities in bromine chemistry, cyanation, sulfur and mercaptan chemistry, cyclopropane and cyclobutane chemistry, and continuous flow chemistry, producing APIs such as Pinaverium Bromide, Myrtecaïne, and Diphenhydramine Methysulfate. M2i monetizes primarily through B2B direct sales to professional agricultural users and pharmaceutical/fine chemistry clients, supplemented by a global distribution partnership with Bayer for biocontrol products and wholly-owned subsidiaries in Chile, Argentina, and Brazil; pricing is quote-based and product/contract terms are not publicly disclosed. The company holds ANSM, FDA, GMP, and ISO 9001 certifications, protects its technology with 40 patent families, and reports that its products help avoid 20,000 tonnes of pesticide use annually.
M2I Life Sciences firmographics
Firmographics- Name
- M2I Life Sciences
- Legal name
- MMLS SA
- Website
- https://m2i-lifesciences.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- M2I Life Sciences is a French industrial group offering pheromone-based biocontrol crop protection products and CDMO custom synthesis services for pharmaceutical and fine chemistry clients, serving professional agriculture and pharma customers across 80 countries.
- Ownership category
- akta.pro rank
M2I Life Sciences industry classification
Industry- Product category
- Agricultural Biocontrol & CDMO
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)
Keywords
Where M2I Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Lacq
- HQ country
- France
- HQ region
- Europe
Offices7 records
Markets served
M2I Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Biocontrol Products: Sale of pheromone-based biocontrol products for crop protection, including various formulations (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) for mating disruption
- CDMO Services: Custom synthesis and contract manufacturing services for pharmaceutical and fine chemicals, from grams to tons scale, including GMP production and regulatory dossier preparation
- Proprietary Molecules Catalog: Sale of proprietary pharmaceutical molecules including APIs, intermediates, pheromones and specialty molecules from catalog
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B professional agricultural products - pricing by quotation |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
M2I Life Sciences product offering
Product offeringCore offering
M2I Life Sciences is a French industrial group operating two divisions: (1) Biocontrol — designing, manufacturing, and selling pheromone-based crop protection products that use mating disruption to replace chemical pesticides, offered in multiple formulation formats and targeting 60+ crops; and (2) Chemistry & Life Sciences (CDMO) — providing custom synthesis and contract manufacturing of pharmaceutical active ingredients, intermediates, and specialty molecules from gram to multi-ton scale, including GMP-certified production and regulatory dossier preparation.
Product overview
M2i Life Sciences is a French industrial group operating two main business divisions: Biocontrol and Chemistry & Life Sciences (CDMO). The Biocontrol division offers pheromone-based crop protection products using mating disruption technology, available in multiple formulation formats (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) and targeted product lines (Frugiperda Pro, Lobesia Pro, Cydia Pro, Grapholita Pro, etc.) protecting 60+ crop types including vineyards, orchards, field crops, and forests. The Chemistry & Life Sciences division provides custom synthesis and contract manufacturing services (CDMO) for pharmaceutical active ingredients, intermediates, and specialty molecules, with proprietary products including Pinaverium Bromide, Myrtecaïne, and Diphenhydramine Methysulfate, plus specialized bromine, sulfur, cyclopropane, and cyclobutane chemistry capabilities. The company operates four sites in France (Lacq, Parnac, Saint-Cloud, Salin-de-Giraud) and three international locations (Chile, Argentina, Brazil).
Differentiator
Problem solved
Functional benefit
Products and services
- Pheromone Biocontrol Product Range (Mating Disruption Formulations)
- Tuta Pro Press Pheromone press formulation targeting tomato leafminer (Tuta absoluta) for professional tomato growers. Launched in 2025 in the Mauritius market.
- Crypto Pro Press Pheromone press formulation for vineyard crop protection, launched in 2025 in the French market as a substitute for conventional chemical pesticides.
- Lobesia Pro Clip Pheromone clip formulation targeting the European grapevine moth (Lobesia botrana) for vineyard protection. Launched in 2025 in the Italian market.
- Eupoecilia Pro Press Pheromone press formulation targeting the grape berry moth (Eupoecilia ambiguella) for vineyard protection. Launched in 2025.
- Lobesia Pro Press Pheromone press formulation targeting the European grapevine moth (Lobesia botrana) for vineyard protection. Technical datasheet dated 2024.
- Cydia Pro Spray Pheromone spray formulation targeting the codling moth (Cydia pomonella) for orchard and market gardening protection.
- CDMO Services (Custom Synthesis and Contract Manufacturing) Custom synthesis and contract manufacturing services for pharmaceutical active ingredients, intermediates, and specialty molecules — from grams to multi-ton industrial scale. Capabilities include bromine chemistry with cyanation, sulfur/mercaptan chemistry, deprotonation by hydrides, energetic chlorinations by POCl3, cyclopropane and cyclobutane chemistry, continuous flow chemistry, GMP-certified production (ANSM, FDA), and regulatory dossier preparation. Serves pharmaceutical and fine chemistry industry clients.
- Organic Polymer Chemistry Services Specialized polymer chemistry and formulation services offering gram-to-kilogram scale synthesis for industrial and pharmaceutical applications.
- Proprietary Pharmaceutical Molecules Catalog (APIs and Intermediates) A catalog of proprietary pharmaceutical active ingredients and intermediates available for contract manufacturing, including Pinaverium Bromide, Trithioanisole, Myrteaïne, Myrteaïne Lauryl Sulfate, Diphenhydramine Methysulfate, and Veratole.
Quantifiable outcome
- 20,000 tonnes of pesticides avoided annually through use of M2i solutions
- +4 more outcomes
Companies that use M2I Life Sciences
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
M2I Life Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
M2I Life Sciences partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- BayercoreBayer has partnered with M2i Group to globally distribute pheromone-based biological crop protection solutions. This strategic partnership leverages Bayer's extensive global agricultural distribution network to expand reach of M2i's sustainable biocontrol products to farmers worldwide.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
M2I Life Sciences competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
M2I Life Sciences social profiles
Digital presenceM2I Life Sciences compliance and trust
Trust signalCompliance4 records
M2I Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
M2I Life Sciences leadership team
Management profileNumber of profiles
Profiles1 record
M2I Life Sciences subsidiaries and ownership
Company hierarchySubsidiaries3 records
M2I Life Sciences funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M2I Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about M2I Life Sciences
What does M2I Life Sciences do?
M2I Life Sciences is a French industrial group operating two divisions: (1) Biocontrol — designing, manufacturing, and selling pheromone-based crop protection products that use mating disruption to replace chemical pesticides, offered in multiple formulation formats and targeting 60+ crops; and (2) Chemistry & Life Sciences (CDMO) — providing custom synthesis and contract manufacturing of pharmaceutical active ingredients, intermediates, and specialty molecules from gram to multi-ton scale, including GMP-certified production and regulatory dossier preparation.
Is M2I Life Sciences a public or private company?
M2I Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.
When was M2I Life Sciences founded?
M2I Life Sciences was founded in 2013. It employs 101 to 250 people.
Where is M2I Life Sciences based?
M2I Life Sciences is headquartered in Lacq, France, in the Europe region.
How does M2I Life Sciences make money?
Three revenue lines are on record. Biocontrol Products are the primary driver. The others are CDMO Services and proprietary Molecules Catalog.
Does M2I Life Sciences have an API?
No public API is recorded for M2I Life Sciences.
What industry is M2I Life Sciences in?
M2I Life Sciences's product category is Agricultural Biocontrol & CDMO. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 3254 and its SIC code is 2834.